Loading...
Last update:  August 22, 2019
23:27 +1GMT

Allergenic Molecule  Ara h 8Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE21153.10020140331, Rockmann H
3.2.1 - Source Sensitized (IgE)2014FranceIgE6833.00020141107, Agabriel C
5.3.1 - Source Exposed (Symptoms, IgE)2014FranceIgE6825.00020141107, Agabriel C
5.3.1 - Source Exposed (Symptoms, IgE)2014JapanIgE160.00020140623, Nozawa A
5.7.2 - Source Exposed (Provocation Test - Ingestion)2013Sweden / USAIgE16743.10020130113, Lieberman JA
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7621.10020131020, van Rhijn BD
5.7.2 - Source Exposed (Provocation Test - Ingestion)2013ItalyIgE4835.00020131128, Calamelli E
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013NetherlandsIgE4254.76020130429, Aalberse JA
5.1.1 - Source Exposed (Symptoms)2013NetherlandsIgE3762.16020130428, Klemans RJ
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3517.14020130605, Simon D
3.2.1 - Source Sensitized (IgE)2013ItalyIgE2433.00020131128, Calamelli E
5.3.1 - Source Exposed (Symptoms, IgE)2013ItalyIgE2437.00020131128, Calamelli E
3.1.4 - Source Sensitized (SPT, IgE)2013NetherlandsIgE2263.64020130429, Aalberse JA
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2013AustriaIgE2095.00020130401, Berneder M
3.2.1 - Source Sensitized (IgE)2013SloveniaIgE1643.75020131106, Homsak M
5.3.1 - Source Exposed (Symptoms, IgE)2013SloveniaIgE1136.36020131106, Homsak M
6.2 - General Population (Adults)2012SwedenIgE3713.50020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9951.12020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE9614.58020120528, Patelis A
3.1.1 - Source Sensitized (SPT)2012SpainIgE7911.39020121016, Javaloyes G
3.1.4 - Source Sensitized (SPT, IgE)2012SpainIgE682.90020120726, Pedrosa M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012SpainIgE557.30020120726, Pedrosa M
5.3.2 - Source Exposed (Symptoms, high IgE)2012TaiwanIgE2913.80020120319, Lin YT
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2011SwedenIgE7470.27020110701, Moverare R
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011NetherlandsIgE1241.67020110304, Vissers YM
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2011NetherlandsIgE8100.00020110304, Vissers YM
5.7.2 - Source Exposed (Provocation Test - Ingestion)2010FranceIgE16639.76020100923, Codrenau F
3.2.1 - Source Sensitized (IgE)2010SwedenIgE10019.00020100212, Asarnoj A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8617.44020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2010FranceIgE6168.85020100923, Codrenau F
5.3.1 - Source Exposed (Symptoms, IgE)2010SpainIgE502.00020101124, Vereda A
4.1.5 - Heterologous Source Sensitized (IgE)2010SwedenIgE5022.00020100212, Asarnoj A
5.3.1 - Source Exposed (Symptoms, IgE)2010SwedenIgE3565.70020101124, Vereda A
5.3.1 - Source Exposed (Symptoms, IgE)2010United StatesIgE3019.10020101124, Vereda A
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3764.86020090826, Ebo DG
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2218.18020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE210.00020090808, Krause S
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2060.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2050.00020091005, Ott H
5.3.1 - Source Exposed (Symptoms, IgE)2004Netherlands / SwitzerlandIgE2085.00020041204, Mittag D
Developed by
Panservice